solifenacin succinate NDC 68462-386

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-386Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0386Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68462-386-14	68462038614	10 BLISTER PACK in 1 CARTON (68462-386-14) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from May 20, 2019
68462-386-30	68462038630	30 TABLET, FILM COATED in 1 BOTTLE (68462-386-30)Marketed from May 20, 2019
68462-386-90	68462038690	90 TABLET, FILM COATED in 1 BOTTLE (68462-386-90)Marketed from May 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): solifenacin succinate
Generic name (nonproprietary): solifenacin succinate
Active ingredients: Solifenacin succinate — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc., USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209239
Marketing start: May 20, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 68462-386_85807e7f-3f25-4df8-812e-fa6b281d559bSPL ID 85807e7f-3f25-4df8-812e-fa6b281d559bSPL set ID 010c0657-c907-477f-8bd7-5d455a5f50ebRxCUI 477367, 477372UNII KKA5DLD701UPC 0368462386309
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462038614 followed by a unit qualifier and the quantity

Package 68462-0386-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2026.

Indications (excerpt from the label)

Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209239

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209239
Product	Strength	Form · route	Labeler	Product NDC
solifenacin succinate	Solifenacin succinate 10 mg/1	Tablet, Film coated, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-387